An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
- Registration Number
- NCT00668655
- Lead Sponsor
- Galderma R&D
- Brief Summary
The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
- Detailed Description
Evaluate the relationship between treatment with MetroGel® 1% and cosmetic performance with the Subjects' usual cosmetic products. It is expected that the female subjects will be able to use their routine cosmetics after application without affecting the cosmetic product's performance or causing side effects.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Subjects with moderate Rosacea (Global Severity Score of 3),
- Subjects willing to stop their current rosacea medication for at least 2 weeks
- Subjects must have an established routine of cosmetics application (e.g. must have been using the same facial foundation for at least 3 months and it is not expected to change during the study)
- Subjects must be willing to use their routine facial foundation and not change products while on study
Exclusion Criteria
- Subjects who do not routinely wear facial foundation
- Subjects who failed to undergo a washout period of 14 days for the use of topical rosacea therapy, (for example: metronidazole, azelaic acid, sulfacetamide)
- Subjects who are unwilling to stop their current rosacea medications for 2 weeks
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Metronidazole Gel Female Subjects aged 20 to 75 inclusive, with a diagnosis of moderate (Global Severity Score of 3) Rosacea
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dermatology Consulting Services
🇺🇸High Point, North Carolina, United States